Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Collaboration and Licensing Deals 2019-2025" has been added to ResearchAndMarkets.com's offering.
This report contains a comprehensive listing of 1390 regenerative medicine deals announced since 2016, including financial terms where available, and links to online deal records of actual regenerative medicine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the world's leading biopharma companies.
Fully revised and updated, the report provides details of regenerative medicine deals from 2019 to 2025. The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, starting with collaborative R&D and commercialization of outcomes. The report includes collaboration, development, research, and licensing deals.
The initial chapters of this report provide an orientation of regenerative medicine dealmaking. They offer insights into several key aspects: the introduction to the report, an overview of trends in regenerative medicine deals since 2019, a look at leading deals by headline value, and a detailed examination of the most active companies in this domain. Additionally, these sections provide a review of deals and partner deals signed and announced since January 2019, categorized by technology type in focus.
The report also includes numerous tables and figures that illustrate the trends and activities in regenerative medicine dealmaking since 2019. In addition, a comprehensive deal directory is provided organized by company A-Z, deal type, and therapeutic target. Each deal title links via Weblink to an online version of the deal record and, where available, the contract document, providing easy access to each contract document on demand.
Regenerative Medicine Collaboration and Licensing Deals provides the reader with the following key benefits:
- Understand deal trends since 2019
- Browse regenerative medicine collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, deal type, and therapy area
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in regenerative medicine dealmaking
2.1. Introduction
2.2. Regenerative medicine deals over the years
2.3. Most active regenerative medicine dealmakers
2.4. Regenerative medicine deals by deal type
2.5. Regenerative medicine deals by therapy area
2.6. Regenerative medicine deals by industry sector
2.7. Deal terms for regenerative medicine deals
2.7.1 Regenerative medicine deals headline values
2.7.2 Regenerative medicine deal upfront payments
2.7.3 Regenerative medicine deal milestone payments
2.7.4 Regenerative medicine royalty rates
Chapter 3 - Leading regenerative medicine deals
3.1. Introduction
3.2. Top regenerative medicine deals by value
Chapter 4 - Most active regenerative medicine dealmakers
4.1. Introduction
4.2. Most active regenerative medicine dealmakers
4.3. Most active regenerative medicine deals company profiles
Chapter 5 - Regenerative medicine contracts dealmaking directory
5.1. Introduction
5.2. Regenerative medicine contracts dealmaking directory
Chapter 6 - Regenerative medicine dealmaking by technology type
Deal directory
Deal directory - Regenerative medicine deals by company A-Z
Deal directory - Regenerative medicine deals by deal type
Deal directory - Regenerative medicine deals by therapy area
Deal type definitions
Companies Featured (Partial)
- 2seventy bio
- 3D-Side
- 3D Medicines
- 3D Systems
- 3T Biosciences
- 4basebio Discovery
- 4D Molecular Therapeutics
- 180 Life Sciences
- 908 Devices
- A*STAR Agency for Science
- Technology and Research
- A*STAR' Institute of Molecular and Cell Biology
- A2 Biotherapeutics
- AavantiBio
- AAVnerGene
- Abbvie
- AbCellera Biologics
- AbelZeta Pharma
- Abeona Therapeutics
- Abintus Bio
- ABL Bio
- Abound Bio
- Abu Dhabi Stem Cells Center
- Abveris
- Academy of Military Medical Sciences (China)
- Accelerated Biosciences
- Accelerator for Technological Research in Genomic Therapies
- Accellix
- Accurus Biosciences
- Acepodia
- aCGT Vector
- Achilles Therapeutics
- Actinium Pharmaceuticals
- ACT Therapeutics
- ActualEyes
- Acuitas Therapeutics
- AdAlta
- Adaptimmune
- Adaptive Biotechnologies
- Adaptive Phage Therapeutics
- Adicet Bio
- Adolore Biotherapeutics
- Adva Biotechnology
- Advanced Biological Innovation and Manufacturing
- Advanced Regenerative Manufacturing Institute
- Adverum Biotechnologies
- Aegis Life
- Aethon Therapeutics
- Affimed Therapeutics
- Affini-T Therapeutics
For more information about this report visit https://www.researchandmarkets.com/r/56uakq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
